| __timestamp | Bristol-Myers Squibb Company | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 15879000000 | 19615600000 |
| Thursday, January 1, 2015 | 16560000000 | 19958700000 |
| Friday, January 1, 2016 | 19427000000 | 21222100000 |
| Sunday, January 1, 2017 | 20776000000 | 22871300000 |
| Monday, January 1, 2018 | 22561000000 | 21493300000 |
| Tuesday, January 1, 2019 | 26145000000 | 22319500000 |
| Wednesday, January 1, 2020 | 42518000000 | 24539800000 |
| Friday, January 1, 2021 | 46385000000 | 28318400000 |
| Saturday, January 1, 2022 | 46159000000 | 28541400000 |
| Sunday, January 1, 2023 | 45006000000 | 34124100000 |
| Monday, January 1, 2024 | 48300000000 | 45042700000 |
Cracking the code
In the competitive landscape of the pharmaceutical industry, revenue growth is a key indicator of success. Over the past decade, Eli Lilly and Bristol-Myers Squibb have demonstrated distinct revenue trajectories. From 2014 to 2023, Bristol-Myers Squibb's revenue surged by approximately 184%, peaking in 2021 with a 46% increase from the previous year. Meanwhile, Eli Lilly experienced a steady growth of around 74% over the same period, with a notable 20% rise in 2023. This divergence highlights Bristol-Myers Squibb's aggressive expansion strategy, particularly evident in the 2020-2021 period, while Eli Lilly's consistent growth underscores its stable market presence. As these pharmaceutical giants continue to innovate and expand, their revenue trends offer valuable insights into their strategic priorities and market dynamics.
Revenue Insights: Eli Lilly and Company and Sanofi Performance Compared
Eli Lilly and Company or Biogen Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Eli Lilly and Company or MiMedx Group, Inc.?
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Revenue Insights: Merck & Co., Inc. and Bristol-Myers Squibb Company Performance Compared
Bristol-Myers Squibb Company and Gilead Sciences, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Bristol-Myers Squibb Company vs United Therapeutics Corporation
Breaking Down Revenue Trends: Bristol-Myers Squibb Company vs Exelixis, Inc.
Bristol-Myers Squibb Company vs Telix Pharmaceuticals Limited: Annual Revenue Growth Compared
Bristol-Myers Squibb Company vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.